Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer

被引：0
|
作者：
Alluri, P. G. [1 ]
Larios, J. M. [1 ]
Malik, R. [1 ]
Hayes, D. F. [1 ]
Speers, C. W. [1 ]
Rae, J. M. [1 ]
Chinnaiyan, A. M. [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P6-12-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-12-05
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer
    Alluri, Prasanna G.
    Larios, Jose
    Malik, Rohit
    Rae, James
    Chiinaiyan, Arul M.
    CANCER RESEARCH, 2016, 76
  • [2] Targeting Estrogen Receptor (ER) Mutations for Treatment of Endocrine Therapy Resistance in Breast Cancer
    Alluri, P. G.
    Larios, J.
    Malik, R.
    Rae, J.
    Chinnaiyan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S53 - S53
  • [3] Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
    Liu, Shuying
    Meng, Xiaolong
    Chen, Huiqin
    Liu, Wenbin
    Miller, Todd
    Murph, Mandi
    Lu, Yiling
    Zhang, Fan
    Gagea, Mihai
    Arteaga, Carlos L.
    Mills, Gordon B.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    ONCOTARGET, 2014, 5 (19) : 9049 - 9064
  • [4] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [5] Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer
    Marquez-Mendoza, J. M.
    Baranda-Avila, N.
    Lizano, M.
    Langley, E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (05):
  • [6] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
  • [7] The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer
    Jeselsohn, Rinath
    De Angelis, Carmine
    Brown, Myles
    Schiff, Rachel
    CURRENT ONCOLOGY REPORTS, 2017, 19 (05)
  • [8] The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer
    Rinath Jeselsohn
    Carmine De Angelis
    Myles Brown
    Rachel Schiff
    Current Oncology Reports, 2017, 19
  • [9] Mismatch repair defects and endocrine therapy resistance in estrogen receptor positive breast cancer
    Haricharan, Svasti
    Schmelz, Jacob
    Schmidt, Cheryl
    Singh, Purba
    Holloway, Kimberly R.
    Anurag, Meenakshi
    Li, Shunqiang
    Kavuri, Shyam M.
    Huang, Shixia
    Edwards, Dean P.
    Suman, Vera
    Hunt, Kelly
    Olson, John A.
    Hoog, Jeremy
    Ma, Cynthia X.
    Bainbridge, Matthew N.
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
  • [10] Inhibition of AKT abrogates resistance to endocrine therapy in estrogen receptor positive breast cancer
    Fox, Emily M.
    Davies, Barry R.
    Arteaga, Carlos L.
    CANCER RESEARCH, 2012, 72
12345